New Systemic Treatment Options for Hepatobiliary Cancers
In recent years, multiple treatment options were added for the first-line treatment of hepatocellular carcinoma as well as for first- and subsequent-line treatment of biliary tract cancers. As molecular profiling can help identify eligibility for more targeted clinical trials or therapies, physicians should consider gene testing. Knowledge of the new therapies will help better inform clinical decision-making.
  • Hepatocellular Carcinoma
  • Recorded Webcast
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation